Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics
NCT01166620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2012-04-13
Summary
To quantify the incremental cost of infections in patients treated with etanercept, adalimumab or infliximab versus abatacept.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2011-09-30
- Completion
- 2012-03-31
More Related Trials
-
Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis
NCT04117165 ·Status: WITHDRAWN ·Phase: NA
-
Dose Escalation With Remicade® and Orencia®
NCT01141413 ·Status: COMPLETED
-
Enbrel Liquid Immunogenicity Protocol
NCT00249041 ·Status: COMPLETED ·Phase: PHASE3
-
Remission Induction in Very Early Rheumatoid Arthritis
NCT00523692 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
NCT00132418 ·Status: COMPLETED ·Phase: PHASE4
-
Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs
NCT03496831 ·Status: COMPLETED
-
The Study of Abatacept in Combination With Etanercept
NCT00162279 ·Status: COMPLETED ·Phase: PHASE2
-
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
NCT00796705 ·Status: TERMINATED ·Phase: PHASE4
-
Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan
NCT02335606 ·Status: COMPLETED
-
A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis
NCT03457792 ·Status: COMPLETED
-
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT03355482 ·Status: TERMINATED ·Phase: PHASE2
-
Socio-economic Determinants for Acceptance and Choice of Biological Treatment
NCT04369651 ·Status: COMPLETED
-
Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis
NCT00989235 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
NCT06712628 ·Status: RECRUITING
-
Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients
NCT01328522 ·Status: COMPLETED ·Phase: PHASE1
-
Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
NCT02874092 ·Status: COMPLETED ·Phase: PHASE4
-
Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis
NCT04343378 ·Status: COMPLETED
-
A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis
NCT04574492 ·Status: COMPLETED
-
Microbial Dysbiosis in Rheumatoid Arthritis
NCT03802890 ·Status: UNKNOWN
-
Information and Acceptability of Biosimilars
NCT04321291 ·Status: UNKNOWN ·Phase: NA
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
Study of Tapering and Discontinuing Biological DMARDs in Rheumatoid Arthritis Patients
NCT04472390 ·Status: UNKNOWN
-
Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)
NCT00115219 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Evaluation of the Radiographic Efficacy of Enbrel
NCT01623752 ·Status: COMPLETED
-
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
NCT00110903 ·Status: COMPLETED ·Phase: PHASE3